Transporters and Drug Discovery: Why, When, and How
- 4 January 2006
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 3 (1) , 26-32
- https://doi.org/10.1021/mp050084o
Abstract
Drug transporters are now increasingly recognized as important determinants of variable drug disposition and response. In addition, transporter associated problems appear to be occurring with greater frequency during the drug discovery and development process. What has not been clear is whether drug transporter related issues are a truly new problem, or whether such issues had existed all along, but were previously unrecognized or ignored. In this review, a brief overview of key drug transporters will be outlined. In addition, a commentary on specific issues of relevance to pharmaceutical sciences in terms of the role and relevance of drug transporters to the drug discovery and development process is provided. Keywords: Drug transport; P-glycoprotein; pharmacokinetics; drug discoveryKeywords
This publication has 31 references indexed in Scilit:
- Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, PravastatinThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceClinical Pharmacology & Therapeutics, 2004
- Impact of Drug Transporter Studies on Drug Discovery and DevelopmentPharmacological Reviews, 2003
- Expression of multidrug resistance‐associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarraysHistopathology, 2002
- Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in ratsGastroenterology, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasisNature Genetics, 1998
- Excretion of GSSG and Glutathione Conjugates Mediated by MRP1 and CM0AT/MRP2Seminars in Liver Disease, 1998
- A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndromeHepatology, 1997
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987